BackCervoMed Overview
CervoMed Inc

CervoMed Target Price

Analysts' average 12-month price target for CervoMed is $8.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.44

Average Target Price

$8.00227.9% upside

2 analysts in the last 4 months

High: $9 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-20Roth Capital$7186.9% upsideOpen
2026-05-18Roth Capital$9268.9% upsideOpen
2025-11-05H.C. WainwrightRaghuram Selvaraju$25924.6% upsideOpen
2025-10-17Roth Capital$20719.7% upsideOpen
2025-08-12Roth CapitalBoobalan Pachaiyappan$16555.7% upsideOpen
2024-09-18Loop Capital MarketsDanill Gataulin$16.32568.9% upsideOpen
2024-09-18Chardan CapitalDaniil Gataulin$16.32568.9% upsideOpen
2024-04-08Canaccord GenuitySumant Kulkarni$19.29690.6% upsideOpen

CervoMed (CRVO) FAQ

CervoMed (CRVO) currently reports a target price of $8. Use the charts on this page to explore CervoMed's target price history and peer comparisons.

Analysts' average 12-month price target for CervoMed is $8, about 227.9% upside from the current share price of $2.44. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $8, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CervoMed, and consider following CRVO for alerts when major investors trade the stock.

CervoMed is classified in the Healthcare sector. On target price, it currently shows $8. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CRVO with unrelated industries.